Population pharmacokinetics of piperacillin using scavenged samples from preterm infants

Therapeutic Drug Monitoring

Volumn 34, Issue 3, 2012, Pages 312-319

  Cohen Wolkowiez, Michael ^a,b   Benjamin, Daniel K ^a,b   Ross, Ashley ^c   James, Laura P ^c   Sullivan, Janice E ^d   Walsh, Michele C ^e   Zadell, Arlene ^e   Newman, Nancy ^e   White, Nicole R ^f   Kashuba, Angela D M ^f   Ouellet, Daniele ^g  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d KOSAIR CHILDREN'S HOSPITAL   (United States)

^e UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^f UNC Hamner Institute for Drug Safety Sciences   (United States)

^g GLAXOSMITHKLINE   (United States)

Author keywords

Drug; Neonate; Pharmacokinetics; Piperacillin

Indexed keywords

CREATININE; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ABDOMINAL INFECTION; ACCURACY; ARTICLE; COMPARTMENT MODEL; CREATININE BLOOD LEVEL; DISTRIBUTION VOLUME; DRUG CLEARANCE; DRUG ELIMINATION; DRUG EXPOSURE; DRUG HALF LIFE; DRUG INFUSION; FEMALE; GESTATIONAL AGE; HUMAN; INFANT; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MONTE CARLO METHOD; NONLINEAR SYSTEM; PERINATAL PERIOD; PREMATURITY; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE;

EID: 84862070752     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e3182587665     Document Type: Article

References (18)

1. Michelow IC, McCracken GH Jr. Antibacterial therapeutic agents. In Feigin RD, ed. Textbook of Pediatric Infectious Diseases. Philadelphia, PA: Saunders; 2004:2990-2991.
2. Reed MD, Goldfarb J, Yamashita TS, et al. Single-dose pharmacokinetics of piperacillin and tazobactam in infants and children. Antimicrob Agents Chemother. 1994;38:2817-2826. (Pubitemid 24374442)
3. Tjandramaga TB, Mullie A, Verbesselt R, et al. Piperacillin: human pharmacokinetics after intravenous and intramuscular administration. Antimicrob Agents Chemother. 1978;14:829-837. (Pubitemid 9074629)
4. Kacet N, Roussel-Delvallez M, Gremillet C, et al. Pharmacokinetic study of piperacillin in newborns relating to gestational and postnatal age. Pediatr Infect Dis J. 1992;11:365-369.
5. Rhodin MM, Anderson BJ, Peters AM, et al. Human renal function maturation: a quantitative description using weight and postmenstrual age. Pediatr Nephrol. 2009;24:67-76.
6. Wade KC, Wu D, Kaufman DA, et al; National Institute of Child Health and Development Pediatric Pharmacology Research Unit Network. Population pharmacokinetics of fluconazole in young infants. Antimicrob Agents Chemother. 2008;52:4043-4049.
7. Cohen-Wolkowiez M, Ouellet D, Smith PB, et al. Population pharmacokinetics of metronidazole evaluated using scavenged samples from preterm infants. Antimicrob Agents Chemother. 2012;56:1828-1837.
8. Wang DD, Zhang S. Standardized visual predictive check versus visual predictive check for model evaluation. J Clin Pharmacol. 2012;52:39-54.
9. Eagye KJ, Kuti JL, Sutherland CA, et al. In vitro activity and pharmacodynamics of commonly used antibiotics against adult systemic isolates of Escherichia coli and Pseudomonas aeruginosa at 40 U.S. hospitals. Clin Ther. 2009;31:2678-2688.
10. Thomson Reuters Clinical Editorial Staff. Neofax 2011. 24th ed. Montvale, NJ: Thomson Reuters; 2011.
11. Tschudy M, Arcara K. The Harriet Lane Handbook: A Manual for Pediatric House Officers. 19th ed. Philadelphia, PA: Mosby; 2011:1035.
12. Choonara I. Unlicensed and off-label drug use in children: implications for safety. Expert Opin Drug Saf. 2004;3:81-83. (Pubitemid 38765189)
13. Roberts R, Rodriguez W, Murphy D, et al. Pediatric drug labeling: improving the safety and efficacy of pediatric therapies. JAMA. 2003; 290:905-911. (Pubitemid 37430462)
14. Suyagh M, Collier PS, Millership JS, et al. Metronidazole population pharmacokinetics in preterm neonates using dried blood-spot sampling. Pediatrics. 2011;127:e367-e374.
15. Arzuaga A, Isla A, Gascón AR, et al. Quantitation and stability of piperacillin and tazobactam in plasma and ultrafiltrate from patients undergoing continuous venovenous hemofiltration by HPLC. Biomed Chromatogr. 2005;19:570-578. (Pubitemid 41448282)
16. Denooz R, Charlier C. Simultaneous determination of five beta-lactam antibiotics (cefepim, ceftazidim, cefuroxim, meropenem and piperacillin) in human plasma by high-performance liquid chromatography with ultraviolet detection. J Chromatogr B Analyt Technol Biomed Life Sci. 2008;864:161-167.
17. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine. Guidance for Industry: Bioanalytical Method Validation. Rockville, MD: Food and Drug Administration; 2001.
18. Fomon SJ, Haschke F, Ziegler EE, et al. Body composition of reference children from birth to age 10 years. Am J Clin Nutr. 1982;35(5 suppl): 1169-1175. (Pubitemid 12008759)